Class IITerminatedD-0424-2015
Drug recall · April 1, 2015
B-Lipo, 30 Capsules recall
Why: Marketed without an Approved NDA/ANDA; found to contain Lorcaserin, a controlled substance used for weight loss
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
B-Lipo, 30 Capsules, Manufactured by KM DALI, Kunming, China for Bethel Nutritional Consulting, Inc.599 West 190th Street, Suite #1 NYC, NY 10040.
- Lots / codes
Lot #: 20213, Exp 12/22/2016.
- Quantity
- UNKNOWN
- Company
- Bethel Nutritional Consulting, Inc, New York, NY
- Distribution
- Nationwide
- Initiated
- December 19, 2014 · Voluntary: Firm initiated
- Classified
- March 24, 2015
- Reported
- April 1, 2015
- Ended
- June 4, 2018
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.